View in EDS PDF Full Text

Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.

Saved in:
Bibliographic Details
Title: Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.
Authors: Siddiqi, Zaeem A.1 (AUTHOR) zsiddiqi@ualberta.ca, Nowak, Richard J.2 (AUTHOR), Mozaffar, Tahseen3 (AUTHOR), O'Brien, Fanny4 (AUTHOR), Yountz, Marcus4 (AUTHOR), Patti, Francesco5 (AUTHOR), Mazia, Claudio Gabriel (AUTHOR), Wilken, Miguel (AUTHOR), Barroso, Fabio (AUTHOR), Saba, Juliet (AUTHOR), Rugiero, Marcelo (AUTHOR), Bettini, Mariela (AUTHOR), Chaves, Marcelo (AUTHOR), Vidal, Gonzalo (AUTHOR), Garcia, Alejandra Dalila (AUTHOR), De Bleecker, Jan (AUTHOR), Van den Abeele, Guy (AUTHOR), de Koning, Kathy (AUTHOR), De Mey, Katrien (AUTHOR), Mercelis, Rudy (AUTHOR)
Source: Muscle & Nerve. Dec2021, Vol. 64 Issue 6, p662-669. 8p.
Database: Academic Search Ultimate
Description
ISSN:0148639X
DOI:10.1002/mus.27422